Gyros closes third funding round
During 2003 Gyros extended its first product line, Gyrolab(TM) MALDI for sample preparation in an automated protein identification setting using mass spectrometry, and launched a second product line, Gyrolab Bioaffy(TM) for protein quantitation. All products are based on the Gyros(TM) technology platform in which laboratory applications are miniaturized and integrated to improve performance and increase efficiency and productivity in the laboratory.
" The past year has been a difficult one in the biotech industry, particularly for those newly entering the market," stated Dr. Maris Hartmanis, CEO at Gyros AB, "We see this funding not only as a signal of strong support from our investors, but also as confirmation that venture capital is still available for those biotech companies that have a sound business proposition".
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.